Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
Clinical trial NCT04530006 · UNKNOWN
Trial details
- NCT number
- NCT04530006
- Sponsor
- CancerCare Manitoba
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2024-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.